Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · IEX Real-Time Price · USD
20.74
+0.10 (0.48%)
At close: Apr 24, 2024, 4:00 PM
20.59
-0.15 (-0.72%)
After-hours: Apr 24, 2024, 5:54 PM EDT
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $617.74 million as of April 24, 2024. Its market cap has decreased by -32.19% in one year.
Market Cap
617.74M
Enterprise Value
194.77M
1-Year Change
-32.19%
Ranking
Category
Stock Price
$20.74
Market Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $617.74M, an increase of 294.72%. That is a compound annual growth rate of 19.89%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 614.80M | 0.39% |
Apr 22, 2024 | 612.40M | 0.99% |
Apr 19, 2024 | 606.40M | 1.24% |
Apr 18, 2024 | 599.00M | 0.10% |
Apr 17, 2024 | 598.40M | -3.03% |
Apr 16, 2024 | 617.10M | -0.15% |
Apr 15, 2024 | 618.00M | -0.15% |
Apr 12, 2024 | 618.90M | -1.39% |
Apr 11, 2024 | 627.60M | -0.41% |
Apr 10, 2024 | 630.20M | -3.25% |
Apr 9, 2024 | 651.40M | 2.92% |
Apr 8, 2024 | 632.90M | -0.14% |
Apr 5, 2024 | 633.80M | 0.33% |
Apr 4, 2024 | 631.70M | 0.29% |
Apr 3, 2024 | 629.90M | -0.57% |
Apr 2, 2024 | 633.50M | -2.52% |
Apr 1, 2024 | 649.90M | 0.56% |
Mar 28, 2024 | 646.30M | 0.05% |
Mar 27, 2024 | 646.00M | 0.28% |
Mar 26, 2024 | 644.20M | -2.31% |
Mar 25, 2024 | 659.40M | 1.51% |
Mar 22, 2024 | 649.60M | 1.20% |
Mar 21, 2024 | 641.90M | -1.96% |
Mar 20, 2024 | 654.70M | 0.97% |
Mar 19, 2024 | 648.40M | 0.19% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SIGA Technologies | 622.76M |
Wave Life Sciences | 621.20M |
Lyell Immunopharma | 619.99M |
Cross Country Healthcare | 617.08M |
Quanterix | 615.78M |
Zymeworks | 604.06M |
ORIC Pharmaceuticals | 590.89M |
GH Research | 587.92M |